Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

PaperCitations, authors & open-access status

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 531 citations, 2020 year and closed oa status.

531
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Gerald W. Prager
Author
The Lancet Oncology
Journal
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Liver Diseases and Immunity
Topic
470M+ articles · free account